Nyumbani › Saratani ya Prostate › Florida › Orlando
Majaribio ya kliniki ya Saratani ya Prostate katika Orlando, FL
Masomo 17 ya Saratani ya Prostate yanatafuta washiriki katika vituo vya Orlando na maeneo yake (ndani ya takriban maili 30). Fungua somo kuona nani anaweza kujiunga na jinsi ya kuwasiliana na timu ya utafiti.
Maandishi rasmi ya utafiti (Kiingereza)
Unavutia washiriki kwa utafiti hapa? Weka juu ya ukurasa huu — $99 kwa siku 30 →
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
InaajiriHatua 1/2
- Advent Health, Orlando
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
InaajiriHatua 2
- AdventHealth Medical Group Oncology Research at Celebration, Kissimmee · Mi 16 mbali
Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
InaajiriHatua 2/3
- AdventHealth, Orlando
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
InaajiriHatua 3
- AdventHealth, Orlando
High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers
InaajiriHatua 2
- Orlando VA Medical Center, Orlando, FL, Orlando
Carboplatin or Olaparib for BRcA Deficient Prostate Cancer
InaajiriHatua 2
- Orlando VA Medical Center, Orlando, FL, Orlando
Sacral Neuromodulation for Male Overactive Bladder (MOAB)
Inaajiri
- AdventHealth, Orlando
First-in-Human Study to Evaluate AZD8359 STEAP2 TCE in Participants With Prostate Cancer
InaajiriHatua 1/2
- Research Site, Orlando
A Study Evaluating the Safety, Pharmacokinetics, and Activity of RO7656594 In Participants With Advanced or Metastatic Prostate Cancer
InaajiriHatua 1
- Sarah Cannon Research Institute @ Florida Cancer, Orlando
A Study to Learn How Safe AZD6621 is, How Well it Works, and How it Moves Throughout the Body Over Time, in Adult Male Participants With Metastatic Prostate Cancer
InaajiriHatua 1/2
- Research Site, Orlando
Neoadjuvant Darolutamide and Relugolix Combination Preceding Radical Prostatectomy for Prostate Cancer
InaajiriHatua 1
- AdventHealth Orlando, Orlando
A Study to Evaluate the Safety, Pharmacokinetics and Efficacy of TJ101 in Patients With Advanced/Metastatic Solid Tumors
InaajiriHatua 1
- Florida Cancer Specialists & Research Institute, Orlando
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
InaajiriHatua 1/2
- Research Site 137, Orlando
- Research Site 118, Celebration · Mi 17 mbali
Building on Trust: Navigating Preventive Lung, Breast, and Prostate Cancer Screenings at Community Resource Spots
InaajiriUtafiti wa uchunguziWajitolea wenye afya wanakaribishwa
- Adventhealth, Orlando
A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid Tumors
InaajiriHatua 1
- Exelixis Clinical Site #8, Orlando
Exploring the Potential of Robotic Telesurgery in Remote Settings
Inaajiri
- AdventHealth, Celebration · Mi 17 mbali
PET Scan Study to Detect Prostate Cancer in Patients with Early PSA Recurrence
InaajiriHatua 2
- AdventHealth, Orlando
Majaribio ya Saratani ya Prostate katika miji mingine
- New York City, NYUtafiti 103
- Houston, TXUtafiti 76
- Los Angeles, CAUtafiti 61
- Boston, MAUtafiti 59
- St. Louis, MOUtafiti 46
- Chicago, ILUtafiti 45
- San Francisco, CAUtafiti 45
- Philadelphia, PAUtafiti 44
- Baltimore, MDUtafiti 43
- Nashville, TNUtafiti 42
- Seattle, WAUtafiti 42
- Washington, DCUtafiti 38
Masomo mengine katika Orlando
- Saratani ya Mapafu Isiyo na Selu NdogoUtafiti 44
- UnenepuUtafiti 31
- Saratani ya MetastasiUtafiti 29
- Uzito Kupita KiasiUtafiti 27
- Ugonjwa wa AlzheimerUtafiti 25
- Kisukari cha Aina ya 2Utafiti 24
- Saratani (aina zote)Utafiti 24
- Saratani ya MatitiUtafiti 23
- Kansari ya MayaiUtafiti 22
- Colitis ya UlcerativeUtafiti 22
- Saratan ya MapafuUtafiti 21
- Kansari ya kolorektaliUtafiti 19
Kutoka ClinicalTrials.gov, data iliyopatikana 5 Okt 2026. Kila utafiti una masharti yake ya kufaa; timu ya utafiti huamua nani anaweza kujiunga.